The start of a new year brings fresh opportunities for innovation and growth in the healthcare sector. However, it also presents a host of challenges that must be addressed in order to improve global health outcomes. In 2026, several emerging trends are set to shape the conversation around biopharma, public health, and disability advocacy.
One of the most pressing issues in public health is the need for greater access to data. As Deborah Birx notes, "Public health data should be just as available and intuitive as a weather app." This sentiment is echoed by many experts who argue that making data more accessible will enable policymakers and healthcare professionals to make more informed decisions. However, this is often easier said than done, particularly in regions where data collection and dissemination are hindered by limited resources.
Meanwhile, the biopharma industry is poised to undergo significant changes in 2026. ATLATL, one of China's leading biotech incubators, is seeking to bridge the gap between East and West by partnering with drugmakers worldwide. This move is reflective of the growing trend towards global collaboration in the biopharma sector. As the industry continues to evolve, experts are watching three key issues closely: the impact of emerging technologies on the development of new treatments, the growing importance of real-world evidence in clinical trials, and the ongoing debate around drug pricing.
In addition to these trends, the biopharma industry will also be shaped by advances in genetic engineering and gene editing technologies. These innovations hold great promise for the treatment of genetic diseases, but they also raise complex ethical questions. Disability advocates, in particular, are watching these developments closely, as they have significant implications for the lives of people with disabilities.
Speaking of disability advocacy, 2026 is set to be a pivotal year for the community. Three key trends are emerging that will shape the conversation around disability and healthcare. Firstly, advocates are pushing for expanded access to primary and emergency care, which is often inadequate for people with disabilities. Secondly, there is a growing debate around the ethics of genetic engineering and its potential impact on people with disabilities. Finally, advocates are seeking to influence the conversation around end-of-life care, which is often shaped by ableist assumptions about the value of life.
Another critical issue in public health is the importance of timely vaccination. A recent study found that babies who don't receive their first round of vaccines on time are much less likely to get vaccinated against measles, mumps, and rubella by age 2. This highlights the need for greater awareness and education around the importance of vaccination, particularly in communities where access to healthcare is limited.
As the world navigates these complex challenges, it is clear that 2026 will be a pivotal year for global health. From biopharma innovation to disability advocacy, there are many emerging trends that will shape the conversation around healthcare. By staying informed and engaged, we can work towards a future where healthcare is more accessible, equitable, and just for all.
Sources:
- Deborah Birx, Opinion: Public health data should be as available as the weather forecast
- ATLATL, A biotech incubator in China tries to unlock innovation — alongside drugmakers worldwide
- STAT+, 3 issues to watch in biopharma in 2026
- Missed first vaccines make babies far more likely to miss measles shot, study finds
- Debates around life, death, and access worry those with disabilities. 3 trends to watch in 2026
The start of a new year brings fresh opportunities for innovation and growth in the healthcare sector. However, it also presents a host of challenges that must be addressed in order to improve global health outcomes. In 2026, several emerging trends are set to shape the conversation around biopharma, public health, and disability advocacy.
One of the most pressing issues in public health is the need for greater access to data. As Deborah Birx notes, "Public health data should be just as available and intuitive as a weather app." This sentiment is echoed by many experts who argue that making data more accessible will enable policymakers and healthcare professionals to make more informed decisions. However, this is often easier said than done, particularly in regions where data collection and dissemination are hindered by limited resources.
Meanwhile, the biopharma industry is poised to undergo significant changes in 2026. ATLATL, one of China's leading biotech incubators, is seeking to bridge the gap between East and West by partnering with drugmakers worldwide. This move is reflective of the growing trend towards global collaboration in the biopharma sector. As the industry continues to evolve, experts are watching three key issues closely: the impact of emerging technologies on the development of new treatments, the growing importance of real-world evidence in clinical trials, and the ongoing debate around drug pricing.
In addition to these trends, the biopharma industry will also be shaped by advances in genetic engineering and gene editing technologies. These innovations hold great promise for the treatment of genetic diseases, but they also raise complex ethical questions. Disability advocates, in particular, are watching these developments closely, as they have significant implications for the lives of people with disabilities.
Speaking of disability advocacy, 2026 is set to be a pivotal year for the community. Three key trends are emerging that will shape the conversation around disability and healthcare. Firstly, advocates are pushing for expanded access to primary and emergency care, which is often inadequate for people with disabilities. Secondly, there is a growing debate around the ethics of genetic engineering and its potential impact on people with disabilities. Finally, advocates are seeking to influence the conversation around end-of-life care, which is often shaped by ableist assumptions about the value of life.
Another critical issue in public health is the importance of timely vaccination. A recent study found that babies who don't receive their first round of vaccines on time are much less likely to get vaccinated against measles, mumps, and rubella by age 2. This highlights the need for greater awareness and education around the importance of vaccination, particularly in communities where access to healthcare is limited.
As the world navigates these complex challenges, it is clear that 2026 will be a pivotal year for global health. From biopharma innovation to disability advocacy, there are many emerging trends that will shape the conversation around healthcare. By staying informed and engaged, we can work towards a future where healthcare is more accessible, equitable, and just for all.
Sources:
- Deborah Birx, Opinion: Public health data should be as available as the weather forecast
- ATLATL, A biotech incubator in China tries to unlock innovation — alongside drugmakers worldwide
- STAT+, 3 issues to watch in biopharma in 2026
- Missed first vaccines make babies far more likely to miss measles shot, study finds
- Debates around life, death, and access worry those with disabilities. 3 trends to watch in 2026